<strong>Background</strong><span style="font-family:Verdana;"> <strong>:</strong></span><span style="font-family:Verdana;">Anxiety and depression are two c...<strong>Background</strong><span style="font-family:Verdana;"> <strong>:</strong></span><span style="font-family:Verdana;">Anxiety and depression are two common psychiatric conditions encountered in cancer treatment. Prevalence rate and risk factors show wide variations in different countries and the environment. COVID 19 outbreak has increased psychological disorders in general public and health workers. Whether this pandemic has increased the psychiatric morbidity in cancer patients need</span><span style="font-family:Verdana;">s</span><span style="font-family:""><span style="font-family:Verdana;"> to be addressed for planning strategies. </span><b><span style="font-family:Verdana;">Methods</span></b></span><b><span style="font-family:Verdana;">: </span></b><span style="font-family:Verdana;">This cross-sectional study was conducted in the Department of Radiation Oncology, a tertiary cancer centre in the state of Kerala, India. The aim was to assess hospital prevalence and risk factors of anxiety and depression among cancer patients during COVID 19 pandemic. Patients on treatment for cancer and willing for the study were recruited. Hospital Anxiety and Depression Scale (HADS)</span><span style="font-family:Verdana;">,</span><span style="font-family:Verdana;"> a self-assessment valid tool for screening both anxiety (HADS-A) and depression (HADS-D) are used. HADS-A &</span><span style="font-family:""> </span><span style="font-family:Verdana;">D were calculated separately & categorized as normal, borderline and abnormal with a score of 0</span><span style="font-family:""> </span><span style="font-family:Verdana;">-</span><span style="font-family:""> </span><span style="font-family:Verdana;">7, 8</span><span style="font-family:""> </span><span style="font-family:Verdana;">-</span><span style="font-family:""> </span><span style="font-family:Verdana;">10 & 11</span><span style="font-family:""> </span><span style="font-family:Verdana;">-</span><span style="font-family:""> </span><span style="font-family:Verdana;">21 respectively. Separate structured questionnaire for COVID19 related questions and patient master file for patient</span><span style="font-family:""> </span><span style="font-family:""><span style="font-family:Verdana;">& treatment characteristics were used in risk assessment. Data were entered in an Excel sheet and SPSS version 22 for statistical analysis. </span><b><span style="font-family:Verdana;">Findings</span></b></span><b><span style="font-family:Verdana;">: </span></b><span style="font-family:Verdana;">208 patients were included in this study. The overall prevalence rate of anxiety was 7</span><span style="font-family:Verdana;">.</span><span style="font-family:Verdana;">2%, with borderline cases 4</span><span style="font-family:Verdana;">.</span><span style="font-family:Verdana;">3% and abnormal cases 2</span><span style="font-family:Verdana;">.</span><span style="font-family:Verdana;">9%. The overall prevalence of the rate of depression was 5</span><span style="font-family:Verdana;">.</span><span style="font-family:Verdana;">3% (3</span><span style="font-family:Verdana;">.</span><span style="font-family:Verdana;">4% borderline & 1</span><span style="font-family:Verdana;">.</span><span style="font-family:Verdana;">9% abnormal). Risk factors like age, sex, socioeconomic status, primary site, stage of the disease and default of disease had no statistical significance.</span><span style="font-family:""> </span><b><span style="font-family:Verdana;">Interpretation</span></b><b><span style="font-family:Verdana;">: </span></b><span style="font-family:Verdana;">The prevalence rate of anxiety and depression among cancer patients in this study is one among the lowest ever reported. COVID 19 outbreak has not brought any impact in the rate of psychological distress in our patients and the low rate may be due to the robust medical care including mental health interventions and reassurance by the Government.</span>展开更多
文摘<strong>Background</strong><span style="font-family:Verdana;"> <strong>:</strong></span><span style="font-family:Verdana;">Anxiety and depression are two common psychiatric conditions encountered in cancer treatment. Prevalence rate and risk factors show wide variations in different countries and the environment. COVID 19 outbreak has increased psychological disorders in general public and health workers. Whether this pandemic has increased the psychiatric morbidity in cancer patients need</span><span style="font-family:Verdana;">s</span><span style="font-family:""><span style="font-family:Verdana;"> to be addressed for planning strategies. </span><b><span style="font-family:Verdana;">Methods</span></b></span><b><span style="font-family:Verdana;">: </span></b><span style="font-family:Verdana;">This cross-sectional study was conducted in the Department of Radiation Oncology, a tertiary cancer centre in the state of Kerala, India. The aim was to assess hospital prevalence and risk factors of anxiety and depression among cancer patients during COVID 19 pandemic. Patients on treatment for cancer and willing for the study were recruited. Hospital Anxiety and Depression Scale (HADS)</span><span style="font-family:Verdana;">,</span><span style="font-family:Verdana;"> a self-assessment valid tool for screening both anxiety (HADS-A) and depression (HADS-D) are used. HADS-A &</span><span style="font-family:""> </span><span style="font-family:Verdana;">D were calculated separately & categorized as normal, borderline and abnormal with a score of 0</span><span style="font-family:""> </span><span style="font-family:Verdana;">-</span><span style="font-family:""> </span><span style="font-family:Verdana;">7, 8</span><span style="font-family:""> </span><span style="font-family:Verdana;">-</span><span style="font-family:""> </span><span style="font-family:Verdana;">10 & 11</span><span style="font-family:""> </span><span style="font-family:Verdana;">-</span><span style="font-family:""> </span><span style="font-family:Verdana;">21 respectively. Separate structured questionnaire for COVID19 related questions and patient master file for patient</span><span style="font-family:""> </span><span style="font-family:""><span style="font-family:Verdana;">& treatment characteristics were used in risk assessment. Data were entered in an Excel sheet and SPSS version 22 for statistical analysis. </span><b><span style="font-family:Verdana;">Findings</span></b></span><b><span style="font-family:Verdana;">: </span></b><span style="font-family:Verdana;">208 patients were included in this study. The overall prevalence rate of anxiety was 7</span><span style="font-family:Verdana;">.</span><span style="font-family:Verdana;">2%, with borderline cases 4</span><span style="font-family:Verdana;">.</span><span style="font-family:Verdana;">3% and abnormal cases 2</span><span style="font-family:Verdana;">.</span><span style="font-family:Verdana;">9%. The overall prevalence of the rate of depression was 5</span><span style="font-family:Verdana;">.</span><span style="font-family:Verdana;">3% (3</span><span style="font-family:Verdana;">.</span><span style="font-family:Verdana;">4% borderline & 1</span><span style="font-family:Verdana;">.</span><span style="font-family:Verdana;">9% abnormal). Risk factors like age, sex, socioeconomic status, primary site, stage of the disease and default of disease had no statistical significance.</span><span style="font-family:""> </span><b><span style="font-family:Verdana;">Interpretation</span></b><b><span style="font-family:Verdana;">: </span></b><span style="font-family:Verdana;">The prevalence rate of anxiety and depression among cancer patients in this study is one among the lowest ever reported. COVID 19 outbreak has not brought any impact in the rate of psychological distress in our patients and the low rate may be due to the robust medical care including mental health interventions and reassurance by the Government.</span>